EU drugs agency endorses Gilead’s remdesivir as Covid-19 therapy
Remdesivir has been approved for emergency use in the US, India and South Korea, and has received full approval in Japan
Bengaluru — Doctors in Europe will soon be able to treat Covid-19 patients with Gilead's antiviral drug, remdesivir, after the health regulator's endorsement put it on track to become the first therapy for the disease on the continent.
The European Medicines Agency (EMA) said on Thursday its human medicines committee recommended conditionally approving the drug for adults and adolescents from 12 years of age who are also suffering from pneumonia and require oxygen support. ..